Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pediatric population with cystic fibrosis in the centre of Portugal: candidates for new therapies.

Jornal de pediatria - 1 Jan 2000

Roda Juliana, Teixeira Teresa, Ai Silva Iris, Silva Teresa Reis, Ferreira Ricardo, Amaral Margarida D, Oliveira Guiomar

Abstract excerpt

OBJECTIVES: Cystic fibrosis (CF) is a severe autosomal recessive disease that results from mutations in a gene encoding the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein, a chloride channel. This study aims to characterize the clinical and genetic features of a cohort of pediatric people with CF (PwCF) in the center of Portugal and to determine which ones are candidates for the new drugs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Cystic Fibrosis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cystic Fibrosis Transmembrane Conductance Regulator

Share to Mutation

Share to Portugal

Source

Open in PubMed Open full text

Identifiers

PMID: 34252371
DOI: 10.1016/j.jped.2021.05.010
PMCID: PMC9432345

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pediatric population with cystic fibrosis in the centre of Portugal: candidates for new therapies.PMID 34252371Read ↗

Update on advances in cystic fibrosis towards a cure and implications for primary care clinicians.Semantic proximity Read ↗

Managing cystic fibrosis in children aged 6-11yrs: a critical review of elexacaftor/tezacaftor/ivacaftor combination therapy.Semantic proximity Read ↗

Cystic fibrosis to CFSPID: Burden of care vs need and rational approach to weaning therapies.Semantic proximity Read ↗

Disease characterization of people with cystic fibrosis and a minimal function mutation: Data from the Italian registry.Semantic proximity Read ↗

Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation.Semantic proximity Read ↗

Unmet challenges in cystic fibrosis treatment with modulators.Semantic proximity Read ↗

Patients eligible for modulator drugs: Data from cystic fibrosis registry of Turkey.Semantic proximity Read ↗

Towards the pharmacogenomics of cystic fibrosis.Semantic proximity Read ↗

Spectrum of CFTR gene sequence variants in a northern Portugal population.Semantic proximity Read ↗

[Therapeutic advances in cystic fibrosis: from genetics to treatment personalized].Semantic proximity Read ↗

[Therapeutic advances in cystic fibrosis in 2014].Semantic proximity Read ↗

What can the CF registry tell us about rare CFTR-mutations? A Belgian study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.